Journal of Clinical Endocrinology & Metabolism, Vol 79, 1063-1069, Copyright © 1994 by Endocrine Society

ARTICLES

Mechanisms of dexamethasone-induced insulin resistance in healthy humans

L Tappy, D Randin, P Vollenweider, L Vollenweider, N Paquot, U Scherrer, P Schneiter, P Nicod and E Jequier
Institute of Physiology, University of Lausanne, Switzerland.

Insulin resistance may result from decreased muscle blood flow, impaired cellular glucose transport, or intracellular deficits of glucose metabolism. The mechanisms responsible for dexamethasone- induced insulin resistance were investigated in healthy human subjects. During a 2-h hyperinsulinemic clamp, dexamethasone decreased glucose uptake, oxidation, and nonoxidative glucose disposal during the first hour. During the second hour, glucose uptake was normalized by means of hyperglycemia; glucose oxidation, however, remained suppressed by dexamethasone. Dexamethasone also abolished the insulin-mediated increase in calf blood flow. When acipimox was administered during the clamps to correct glucocorticoid-induced inhibition of glucose oxidation, dexamethasone decreased whole body glucose uptake and nonoxidative glucose disposal in the same proportion as when no acipimox was administered. However, glucose oxidation and insulin- mediated calf blood flow were normalized after acipimox. During the second hour, exogenous glucose infusion was matched to that used in the control clamp and normalized whole body glucose uptake. However, hyperglycemia developed, indicating insulin resistance. It is concluded that dexamethasone 1) decreases glucose oxidation independently of glucose transport; this inhibition is reversed by acipimox; and 2) decreases whole body glucose uptake independently of increased lipolysis, decreased glucose oxidation, or an altered muscle blood flow.

This article has been cited by other articles:

				D. P Macfarlane, S. Forbes, and B. R Walker Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome J. Endocrinol., May 1, 2008; 197(2): 189 - 204. [Abstract] [Full Text] [PDF]

				C. Corporeau, C. L. Foll, M. Taouis, J.-P. Gouygou, J.-P. Berge, and J. Delarue Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E78 - E86. [Abstract] [Full Text] [PDF]

				J. Rosen and J. N. Miner The Search for Safer Glucocorticoid Receptor Ligands Endocr. Rev., May 1, 2005; 26(3): 452 - 464. [Abstract] [Full Text] [PDF]

				S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF]

				D. Qi, T. Pulinilkunnil, D. An, S. Ghosh, A. Abrahani, J. A. Pospisilik, R. Brownsey, R. Wambolt, M. Allard, and B. Rodrigues Single-Dose Dexamethasone Induces Whole-Body Insulin Resistance and Alters Both Cardiac Fatty Acid and Carbohydrate Metabolism Diabetes, July 1, 2004; 53(7): 1790 - 1797. [Abstract] [Full Text] [PDF]

				C. G. Perry, A. Spiers, S. J. Cleland, G. D. O. Lowe, J. R. Petrie, and J. M. C. Connell Glucocorticoids and Insulin Sensitivity: Dissociation of Insulin's Metabolic and Vascular Actions J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6008 - 6014. [Abstract] [Full Text] [PDF]

				L. Tappy, P. Schneiter, R. Chiolero, V. Bettschart, and M. Gillet Effects of a Glucose Meal on Energy Metabolism in Patients With Cirrhosis Before and After Liver Transplantation Arch Surg, January 1, 2001; 136(1): 80 - 84. [Abstract] [Full Text] [PDF]

				R. E. Shangraw and F. Jahoor Lipolysis and lipid oxidation in cirrhosis and after liver transplantation Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G967 - G973. [Abstract] [Full Text] [PDF]

				L. Mantha and Y. Deshaies Energy intake-independent modulation of triglyceride metabolism by glucocorticoids in the rat Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1424 - R1432. [Abstract] [Full Text] [PDF]

				L. Mantha, E. Palacios, and Y. Deshaies Modulation of triglyceride metabolism by glucocorticoids in diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R455 - R464. [Abstract] [Full Text] [PDF]

				P. Schneiter and L. Tappy Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E806 - E813. [Abstract] [Full Text] [PDF]

				N. A. T. M. Huizenga, J. W. Koper, P. de Lange, H. A. P. Pols, R. P. Stolk, H. Burger, D. E. Grobbee, A. O. Brinkmann, F. H. de Jong, and S. W. J. Lamberts A Polymorphism in the Glucocorticoid Receptor Gene May Be Associated with an Increased Sensitivity to Glucocorticoids in Vivo J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 144 - 151. [Abstract] [Full Text]